methyl 8-ethynyl-6-(pyridin-2-yl)-4H-benzo[f]imidazo[1,5-a][1,4]diazepine-3-carboxylate

ID: ALA4537371

PubChem CID: 88286432

Max Phase: Preclinical

Molecular Formula: C20H14N4O2

Molecular Weight: 342.36

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  C#Cc1ccc2c(c1)C(c1ccccn1)=NCc1c(C(=O)OC)ncn1-2

Standard InChI:  InChI=1S/C20H14N4O2/c1-3-13-7-8-16-14(10-13)18(15-6-4-5-9-21-15)22-11-17-19(20(25)26-2)23-12-24(16)17/h1,4-10,12H,11H2,2H3

Standard InChI Key:  LWYYAGMSQFPJGP-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 26 29  0  0  0  0  0  0  0  0999 V2000
    8.9093   -9.4389    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.9081  -10.2585    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.6162  -10.6674    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.6144   -9.0301    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.3223  -10.2576    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.3230   -9.4353    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.9704  -10.7729    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.7767  -10.5866    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   12.1315   -9.8395    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.9664   -8.9139    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.7743   -9.0959    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.1972   -8.3838    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.6505   -7.7616    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.8900   -8.0892    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.7906  -11.5666    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.0088  -11.8082    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8285  -12.6044    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.4290  -13.1599    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.2127  -12.9136    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.3893  -12.1179    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   13.0132   -8.3824    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.4230   -9.0894    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   13.4205   -7.6740    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   14.2377   -7.6726    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2043  -10.6663    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4963  -11.0743    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  5  2  0
  6  4  2  0
  4  1  1  0
  5  6  1  0
  6 10  1  0
  5  7  1  0
  7  8  2  0
 11  9  1  0
  8  9  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 10  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 15  1  0
  7 15  1  0
 12 21  1  0
 21 22  2  0
 21 23  1  0
 23 24  1  0
 25 26  3  0
  2 25  1  0
M  END

Associated Targets(Human)

GABRA1 Tclin GABA receptor alpha-1 subunit (399 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GABRA2 Tclin GABA receptor alpha-2 subunit (271 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GABRA3 Tclin GABA receptor alpha-3 subunit (187 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GABRA5 Tclin GABA receptor alpha-5 subunit (699 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 342.36Molecular Weight (Monoisotopic): 342.1117AlogP: 2.39#Rotatable Bonds: 2
Polar Surface Area: 69.37Molecular Species: NEUTRALHBA: 6HBD:
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 3.05CX LogP: 2.61CX LogD: 2.61
Aromatic Rings: 3Heavy Atoms: 26QED Weighted: 0.53Np Likeness Score: -0.77

References

1. Maramai S, Benchekroun M, Ward SE, Atack JR..  (2020)  Subtype Selective γ-Aminobutyric Acid Type A Receptor (GABAAR) Modulators Acting at the Benzodiazepine Binding Site: An Update.,  63  (7): [PMID:31738537] [10.1021/acs.jmedchem.9b01312]

Source